H.R. 1563

Summary

H.R. 1563, the STOP Fentanyl and Xylazine Act, was introduced in the House on Feb 25, 2025 by Rep. Jasmine Crockett (D) with 1 co-sponsor. It was referred to Judiciary, and last saw action on Feb 25, 2025: Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Record

Text

H.R. 1563 has 1 co-sponsor.

119 HR 1563 IH: Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act
 U.S. House of Representatives
 2025-02-25
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I  119th CONGRESS  1st Session  H. R. 1563  IN THE HOUSE OF REPRESENTATIVES   February 25, 2025   Ms. Crockett  (for herself and  Mr. Gooden ) introduced the following bill; which was referred to the  Committee on the Judiciary , and in addition to the Committee on  Energy and Commerce , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned   A BILL
To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful.
1.
Short title
This Act may be cited as the   Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act   or the   STOP Fentanyl and Xylazine Act  .
2.
Clarification regarding the treatment of equipment that indicates the presence of fentanyl or xylazine in a compound
Section 422 of the Controlled Substances Act ( 21 U.S.C. 863 ) is amended by adding at the end the following:
(g)
Clarification
This section does not apply to the possession, sale, purchase, importation, exportation, or transportation of equipment for which the intended use is to indicate the presence of fentanyl or xylazine in a compound.
 .

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

CRS Summary

The summaries are the Congressional Research Service’s, one per stage. Read them in full.

Sponsors

Rep. Jasmine Crockett (D) sponsors H.R. 1563, and 1 member has co-sponsored it from the day it was introduced.

Jasmine Crockett

Rep. · D–TX-30 · Sponsor

Introduced Feb 25, 2025

Lance Gooden

Rep. · R–TX-5 · Co-sponsor

Joined Feb 25, 2025 · Original

Show 2 of 2 rows

PreviousNext

Committees

H.R. 1563 went before 2 committees: Energy and Commerce and Judiciary.

Energy and Commerce

Energy and Commerce

Referred To · Feb 25, 2025 · 1,636 Bills

Judiciary

Judiciary

Referred To · Feb 25, 2025 · 2,181 Bills

Actions

H.R. 1563 has taken 2 actions since Feb 25, 2025.

Votes

H.R. 1563 has not gone to a roll call.

Titles

H.R. 1563 goes by 4 titles, 2 of them short titles.

• STOP Fentanyl and Xylazine Act — Display Title
• STOP Fentanyl and Xylazine Act — Short Title(s) as Introduced
• Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act — Short Title(s) as Introduced
• To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful. — Official Title as Introduced

Classification

The Congressional Research Service files H.R. 1563 under Crime and Law Enforcement, one of its 31 policy areas, and gives it 2 legislative subjects.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 1563’s is Crime and Law Enforcement.

Legislative Subjects

H.R. 1563 carries 2 of CRS’s legislative subjects, from Criminal procedure and sentencing to Drug trafficking and controlled substances.

Source: congress.gov · legiscan.com